Clinical Trial Update: An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of telaprevir in patients with chronic hepatitis C co-infected with HIV-1. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED